Finally, although this was the first longitudinal study to determine the effects of adjuvant medications among patients receiving insulin for type 1 diabetes over a 7-year period in the real-world settings documented in a national database, certain small subgroups of patients may have been affected by type 2 error. Here, INS is linked to type 1 diabetes mellitus.